Observatoire des droits humains (anglais seulement)

Study: Cholesterol Drug Modestly Lowers Risk of Heart Attack, Death

(Version anglaise seulement)

A newer cholesterol drug, used with older statin medicines, modestly lowered heart risks and deaths in a big study of heart attack survivors that might persuade insurers to cover the pricey treatment more often. Results on the drug, Praluent, were announced Saturday at an American College of Cardiology conference in Florida. It’s the first time a cholesterol-lowering drug has reduced deaths since statins such as Lipitor and Crestor came out decades ago. “It’s the ultimate...

Lire l'article complet